Evidence map›Paper›PMID 27286814›Full record

ArticleBMC infectious diseases2016

The incidence of tuberculosis among hiv-positive individuals with high CD4 counts: implications for policy.

Tendesayi Kufa, Violet Chihota, Victor Mngomezulu, Salome Charalambous, Suzanne Verver, Gavin Churchyard, Martien Borgdorff

Abstract read
In one paragraph

Article in BMC infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tendesayi KufaThe Aurum Institute, 29 Queens Road, Parktown, Johannesburg, 2193, South Africa. tendesayikc@nicd.ac.za.
Violet ChihotaThe Aurum Institute, 29 Queens Road, Parktown, Johannesburg, 2193, South Africa.
Victor MngomezuluDepartment of Diagnostic Radiology, University of the Witwatersrand, Johannesburg, South Africa.
Salome CharalambousThe Aurum Institute, 29 Queens Road, Parktown, Johannesburg, 2193, South Africa.
Suzanne VerverKNCV Tuberculosis Foundation, The Hague, The Netherlands.
Gavin ChurchyardThe Aurum Institute, 29 Queens Road, Parktown, Johannesburg, 2193, South Africa.
Martien BorgdorffAcademic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIntensified case finding (ICF) and earlier antiretroviral therapy (ART) initiation are strategies to reduce burden of HIV-associated tuberculosis (TB). We describe incidence of and associated factors for TB among HIV-positive individuals with CD4 counts > 350 cells/μl in South Africa.

methodsProspective cohort study of individuals recruited for a TB vaccine trial. Eligible individuals without prevalent TB were followed up at 6 and 12 months after enrolment. Cox proportional hazards regression was used to determine factors associated with risk of incident TB.

resultsSix hundred thirty-four individuals were included in the analysis [80.9 % female, 57.9 % on ART, median CD4 count 562 cells/μl (IQR 466-694 cells/μl)]. TB incidence was 2.7 per 100 person-years (pyrs) (95 % CI 1.6-4.4 per 100 pyrs) and did not differ significantly between those on ART and those not on ART [HR 0.65 (95 % CI 0.24-1.81)]. Low body mass index (BMI <18.5 kg/m(2)) was associated with incident TB [HR 3.87 (95 % CI 1.09-13.73)]. Half of the cases occurred in the first 6 months of follow up and may have been prevalent or incubating cases at enrolment.

conclusionsTB incidence was high and associated with low BMI. Intensified case finding for TB should be strengthened for all HIV positive individuals regardless of their CD4 count or ART status.

Indexed as

CD4 Lymphocyte CountAdultAnti-HIV AgentsBody Mass IndexCohort StudiesFemaleHIV InfectionsHumansIncidenceMalePrevalenceProportional Hazards ModelsProspective StudiesSouth AfricaTuberculosisAnti-HIV AgentsAntiretroviralCaseFindingIntensifiedTherapy

Identifiers

PMID27286814
PMCPMC4901468

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.